Conference Code: 21CH04ICICIDR
International Research Conference Aims and Objectives
The ICICIDR 2021: 23rd International Conference on Immunotoxicology, Cellular Immunology and Drug Rehabilitation
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Immunotoxicology, Cellular Immunology and Drug Rehabilitation. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Immunotoxicology, Cellular Immunology and Drug Rehabilitation.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Immunotoxicology, Cellular Immunology and Drug Rehabilitation are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI)
, Google Scholar
, Semantic Scholar
, and other index databases. Impact Factor Indicators
Special Journal Issues
has teamed up with the Special Journal Issue on Immunotoxicology, Cellular Immunology and Drug Rehabilitation
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form
|Abstracts/Full-Text Paper Submission Deadline
||June 20, 2020
|Notification of Acceptance/Rejection
||October 30, 2020
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline
||December 6, 2020
||April 20 - 21, 2021
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for
Please refer to the Paper Submission GUIDE
before submitting your paper.
Selected Conference Papers
1) Comparison of the Use of Vaccines or Drugs against Parasitic DiseasesH. Al-Khalaifa, A. Al-Nasser 2) The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) RegionsS. Ramia, N. Melhem, K. Kreidieh 3) Displaying of GnRH Peptides on Bacteriophage T7 and Its Immunogenicity in Mice ModelHai Xu, Yiwei Wang, Xi Bao, Bihua Deng, Pengcheng Li, Yu Lu 4) Vaccinated Susceptible Infected and Recovered (VSIR) Mathematical Model to Study the Effect of Bacillus Calmette-Guerin (BCG) Vaccine and the Disease Stability AnalysisMuhammad Shahid, Nasir-uddin Khan, Mushtaq Hussain, Muhammad Liaquat Ali, Asif Mansoor 5) Hepatitis B Virus Infection among Egyptian Children Vaccinated during InfancyIman I. Salama, Samia M. Sami, Somaia I. Salama, Zeinab N. Said, Thanaa M. Rabah, Aida M. Abdel-Mohsin 6) Unnoticeable Mumps Infection in India: Does MMR Vaccine Protect against Circulating Mumps Virus Genotype C?Jeevan Malayan, Aparna Warrier, Padmasani Venkat Ramanan, Sanjeeva Reddy N, Elanchezhiyan Manickan 7) The Influence of Heat Treatment on Antimicrobial Proteins in MilkJelena Zagorska, Inga Ciprovica 8) Immune Responce in Mice Immunized with Live Cold-Adapted Influenza Vaccine in Combination with Chitosan-Based AdjuvantsNelly К. Akhmatova, Оlga V. Lebedinskaya, Ancha V. Baranova, Еlena А. Lebedinskaya,
Ekaterina V. Sorokina, Elvin А. Akhmatov, Аnatoliy P. Godovalov, Stanislav G. Markushin 9) Chitosan Nanoparticle as a Novel Delivery System for A/H1n1 Influenza Vaccine: Safe Property and Immunogenicity in MiceNguyen Anh Dzung, Nguyen Thi Ngoc Hà, Dang Thi Hong Van, Nguyen Thi Lan Phuong, Nguyen Thi
Nhu Quynh, Dinh Minh Hiep, Le Van Hiep 10) Implementation of a “DIVA“ Concept withspecific Elisa Kits; When Subunit H5 Avian Influenza Vaccine is usedRobles F, Uribe A, Guadarrama A , Castellanos L, González C.
Similar conferences about Medical and Health Sciences